Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis-Reference-Cited by-同舟云学术

Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis

Published:2017-03-15 Issue: Volume:8 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Carneiro Priscila J.,Clevelario Amanda L.,Padilha Gisele A.,Silva Johnatas D.,Kitoko Jamil Z.,Olsen Priscilla C.,Capelozzi Vera L.,Rocco Patricia R. M.,Cruz Fernanda F.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Ministério da Saúde

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Seventh Framework Programme

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference80 articles.

1. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies;Ahluwalia;Cancer Lett.,2010

2. Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia;Amsberg;Onco Targets Ther.,2013

3. Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury;Araujo;Crit. Care Med.,2010

4. Volume-time profile during relaxed expiration in the normal dog;Bates;J. Appl. Physiol.,1985

5. Macrophage heterogeneity in respiratory diseases;Boorsma;Mediators Inflamm.,2013

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing screen identifies novel anti-inflammatory activity of sunitinib in macrophages;European Journal of Pharmacology;2024-04

2. Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibition;Frontiers in Pharmacology;2024-02-21

3. Macrophage-related therapeutic strategies: Regulation of phenotypic switching and construction of drug delivery systems;Pharmacological Research;2024-01

4. Macrophage-derived MMP12 promotes fibrosis through sustained damage to endothelial cells;Journal of Hazardous Materials;2024-01

5. The Peptide DHα-(4-pentenyl)-ANPQIR-NH₂Exhibits Antifibrotic Activity in Multiple Pulmonary Fibrosis Models Induced by Particulate and Soluble Chemical Fibrogenic Agents;Journal of Pharmacology and Experimental Therapeutics;2023-12-21